Antibe Therapeutics Inc.
OTC: ATBPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Daniel Marcel Legault
- Employees
- 11
- Headquarters
- Toronto, Canada
- IPO year
- 2014
- Market cap
- $11.4M
- Website
- https://www.antibethera.com
Loading ATBPF…
Loading profile data…Frequently asked questions about ATBPF
What does Antibe Therapeutics Inc. (ATBPF) do?
Antibe Therapeutics Inc. is a biotechnology company focused on the innovation and development of novel therapeutic solutions and medical devices. The firm operates across Canada, Europe, the United States, and other international markets, concentrating its efforts on pain management, inflammation, and regenerative medicine. A key characteristic...
Where does ATBPF trade?
Antibe Therapeutics Inc. (ATBPF) trades on the Other OTC.
What sector is ATBPF in?
Antibe Therapeutics Inc. (ATBPF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Antibe Therapeutics Inc.?
Daniel Marcel Legault is the chief executive officer of Antibe Therapeutics Inc. (ATBPF).
Where is Antibe Therapeutics Inc. headquartered?
Antibe Therapeutics Inc. is headquartered in Canada.
Does ATBPF pay a dividend?
Antibe Therapeutics Inc. (ATBPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATBPF go public?
Antibe Therapeutics Inc. (ATBPF) completed its initial public offering in 2014.